A step closer to legalizing magic mushrooms as FDA lets second research group use the ‘breakthrough’ drug in clinical trial to treat 80 patients with depression
FDA official designated Ursona Institute’s phase 2 clinical trials using psilocybin to treat depression in 80 patients Breakthrough Therapy status…